Scientists have managed to capture the „start-up“ process of a crucial receptor in our bodies through a new study involving FAU. This significant breakthrough could pave the way for creating more efficient medicines in the future. Learn more: http://idw-online.de/de/news830230
Study involving FAU may lead to the development of improved medicines
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.